|
CN105311625A
|
|
Pharmaceutical composition containing recombinant human granulocyte colony-stimulating factors
|
|
CN105316384A
|
|
Synthetic method for prostaglandin E1
|
|
CN105311624A
|
|
Pharmaceutical composition containing recombinant human erythropoietin
|
|
CN105310988A
|
|
Freeze-dried pharmaceutical composition containing recombinant human interferon alpha2b
|
|
CN105395535A
|
|
Emulsifiable paste medicine composition containing ibuprofen
|
|
CN104042574A
|
|
Lyophilized medicinal composition containing ganciclovir and preparation method thereof
|
|
CN104043129A
|
|
Lyophilized medicinal composition containing recombinant human granulocyte macrophage colony-stimulating factor and preparation method thereof
|
|
CN104043128A
|
|
Pharmaceutical composition containing tegafur and preparation method thereof
|
|
CN104055777A
|
|
Lyophilized drug combination containing methionined B1 and preparing method thereof
|
|
CN104043112A
|
|
Ointment pharmaceutical composition containing recombinant human interferon alpha-2b (pseudomonas) and preparation method of ointment pharmaceutical composition
|
|
CN103690496A
|
|
Freeze-drying medicine composition containing sodium ozagrel
|
|
CN103690484A
|
|
Medicine composition containing alprostadil and preparation method of medicine composition
|
|
CN103690935A
|
|
Freeze-drying medicine composition containing thymalfasin
|
|
CN103705908A
|
|
Lyophilized pharmaceutical composition containing thymopentin and preparation method thereof
|
|
CN103705474A
|
|
Lyophilized pharmaceutical composition containing omeprazole sodium
|
|
CN103014101A
|
|
Purifying method of interferon
|
|
CN103014100A
|
|
Purifying method for recombinant human granulocyte stimulating factor
|
|
CN102949353A
|
|
oxaliplatin lyophilized pharmaceutical composition for injection and
|
|
CN102885765A
|
|
Irinotecan hydrochloride injection and preparation method thereof
|
|
CN102764241A
|
|
Freeze-dried pharmaceutical composition containing gemcitabine hydrochloride
|
